These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7448696)

  • 21. [Value of the assay of squamous cell carcinoma in cancer of the uterine cervix].
    Gosselin P; Cazin JL; Dehaut JP; Sulman C; Baranzelli MC; Demaille MC
    Presse Med; 1987 Oct; 16(34):1677-9. PubMed ID: 2959941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for specific tumor cytotoxic antibodies in serum of cervical cancer patients.
    Weintraub I; Klisak I; Lagasse LD; Byfield JE
    Am J Obstet Gynecol; 1973 Aug; 116(7):985-92. PubMed ID: 4124024
    [No Abstract]   [Full Text] [Related]  

  • 23. Depressed lectin-dependent cell-mediated cytotoxicity against adherent HEP-2 cells in patients with carcinoma of the uterine cervix.
    Perl A; Gonzalez-Cabello R; Láng I; Somos P; Gergely P
    Cancer Immunol Immunother; 1983; 15(2):155-8. PubMed ID: 6553513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T and B lymphocytes in patients with squamous cell carcinoma of the uterine cervix.
    Ishiguro T; Sugitachi I; Katoh K
    Gynecol Oncol; 1980 Feb; 9(1):80-5. PubMed ID: 6965486
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of immune lymphocytes to detect expression of herpetic genome.
    Sprecher-Goldberger S; Thiry L; Vandenbussche P
    Nature; 1974 Aug; 250(5468):678-9. PubMed ID: 4369425
    [No Abstract]   [Full Text] [Related]  

  • 26. Cytotoxicity of lymphocytes to established cultures of human tumors: evidences for specificity.
    Sinkovics JG; Tebbi K; Cabiness JR
    Natl Cancer Inst Monogr; 1973 Jun; 37():9-18. PubMed ID: 4123456
    [No Abstract]   [Full Text] [Related]  

  • 27. [Significance of determination of squamous cell carcinoma antigen in the follow up of patients with cancer of the uterine cervix].
    Göcze P; Vahrson H
    Orv Hetil; 1992 Dec; 133(50):3191-4. PubMed ID: 1461640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tumor antigen TA-4 of squamous cell carcinoma in patients with cervical cancer].
    Kato H; Morioka H; Aramaki S; Tamai K; Nagaya T; Nagai M; Torigoe T
    Gan No Rinsho; 1984 May; 30(6 Suppl):574-7. PubMed ID: 6748228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytochemical and immunologic of women treated for squamous cell carcinoma of the cervix.
    Olkowski ZL; McLaren JR; Wilkins SA; Maruszczak AJ; Kirchner AB
    AJR Am J Roentgenol; 1977 May; 128(5):839-42. PubMed ID: 404913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody cytotoxicity studies in ovarian and cervical malignancies.
    Disaia PJ; Nalick RH; Townsend DE
    Obstet Gynecol; 1973 Nov; 42(5):644-50. PubMed ID: 4796001
    [No Abstract]   [Full Text] [Related]  

  • 31. Depression of high-affinity rosette formation in dysplasia and carcinoma in situ of the uterine cervix: mediation by serum factors.
    Bashford J; Gough IR
    Cancer Res; 1983 Aug; 43(8):3959-62. PubMed ID: 6861159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of the tumor antigen TA-4 in squamous cell carcinoma of the uterine cervix.
    Kato H; Morioka H; Aramaki S; Tamai K; Torigoe T
    Am J Obstet Gynecol; 1983 Feb; 145(3):350-4. PubMed ID: 6824024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood group antigen expression and prognosis in squamous cell carcinoma of the uterine cervix.
    Lindgren A; Stendahl U; Brodin T; Lundblad A; Sällström J; Busch C
    Anticancer Res; 1986; 6(2):255-8. PubMed ID: 2423015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
    Rivera ES; Hersh EM; Bowen JM; Barnett JW; Wharton T; Murphy SG
    Cancer; 1979 Jun; 43(6):2297-305. PubMed ID: 455220
    [No Abstract]   [Full Text] [Related]  

  • 35. Generation of memory CD4+, CD8+, CD45RO+ and CD16- lymphocytes activated with IL-2, INF-gamma, and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture.
    Rangel R; Rocha L; Ramirez JL; Ibarra MJ; Solorza G; Monroy A; Ramirez MA; Herrera A; Weiss-Steider B
    Eur Cytokine Netw; 1995; 6(3):195-202. PubMed ID: 8589277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoglobulins in carcinoma of the uterine cervix.
    Plesnicar S
    Acta Radiol Ther Phys Biol; 1972 Feb; 11(1):37-47. PubMed ID: 4623041
    [No Abstract]   [Full Text] [Related]  

  • 37. Natural killer cell activity in patients with invasive cervical carcinoma: importance of a longitudinal evaluation in follow-up.
    Garzetti GG; Ciavattini A; Muzzioli M; Goteri G; Mannello B; Romanini C; Fabris N
    Gynecol Obstet Invest; 1995; 40(2):133-8. PubMed ID: 8575692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does preoperative serum squamous cell carcinoma antigen level predict occult extracervical disease in patients with stage Ib invasive squamous cell carcinoma of the cervix?
    Patsner B; Orr JW; Allmen T
    Obstet Gynecol; 1989 Nov; 74(5):786-8. PubMed ID: 2812656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of immunology in the diagnosis, prognosis and treatment planning of oral cancer.
    Shillitoe EJ
    Proc R Soc Med; 1976 Oct; 69(10):747-9. PubMed ID: 186794
    [No Abstract]   [Full Text] [Related]  

  • 40. In vivo and in vitro measurements of the relationship of human squamous carcinomas to herpes simplex virus tumor-associated antigens.
    Hollinshead AC; Chretien PB; Lee OB; Tarpley JL; Kerney SE; Silverman NA; Alexander JC
    Cancer Res; 1976 Feb; 36(2 pt 2):821-8. PubMed ID: 56226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.